Patient Registry Software Market: Current Analysis and Forecast (2021-2027)

$4999$8699

Emphasis on Type of Registry (Disease Registry, Health Service Registry, and Product Registry); Type of Software (Standalone and Integrated); Functionality (Population Health Management, Health Information Exchange, Patient Care Management, Point-Of-Care, Medical Research & Clinical Studies, and Product Outcome Evaluation); Database Type (Commercial and Public); Deployment Model (On-premise and Web/Cloud-based); End-use (Government & third parties, Hospitals & medical practices, private payers, pharma & medical device companies, and research organization); and Region/Country

Published:

Dec-2021

Pages:

327

Table:

62

Figure:

132

Report ID:

UMHE21564

Geography:

Clear
  Get a Sample
SKU: UMHE21564 Categories: ,
Report Description
Table of content
Research Methodology

Report Description


Patient Registry Software Market is expected to register a CAGR of 15% during the forecast period (2021-2027).
Patient registry software is used to capture, manage, and provide data on specific conditions to support organized care management of patients with chronic diseases. The exploitation of medical information from clinical registries is progressively improving all over the world. Clinical registries capture broad-scope data by using a mixture of manual and automated methods. As per a survey by the American Medical Association, published in the Journal for Electronic Health Data and Methods in 2018, the Centers of Medicare and Medicaid use around 70% of data of over 50 specialty clinical registries in the US for measuring the quality of clinical care through patient registries. The demand for the Patient Registry Software market is burgeoning on account of the increasing adoption of Electronic Health Records and other eHealth solutions all over the world. The patient registry software functionality is integrated as an add-on for many EHR products. Numerous Countries are focusing on the higher adoption of EHR solutions in their healthcare systems for the delivery of effective healthcare services. As per HealthIt.gov, nearly 9 in 10 (86%) of office-based physicians had adopted EHR, and nearly 4 in 5 (80%) had adopted a certified EHR. The rising exploitation of EHR in developed as well as developing countries is leading to improved patient care, expanded patient participation, and easy collection and storage of patient health information in a digital format. In addition, the increasing pressure to improve the quality of care and reduce healthcare costs, and the growing use of patient registry data for post-market surveillance also boost the market growth.

Value-Based Health Care Benefits

Insights Presented in the Report

“Amongst Type of Registry, Disease Registry segment hold the major share.”

Based on the Type of Registry, the market is fragmented into Disease Registry, Health Service Registry, and Product Registry. The Disease Registry segment dominated the market in 2020 and is expected to grow at lucrative growth owing to the rise in the aging population, increasing prevalence of chronic diseases, rising awareness on the role of registries in health management, and the adoption of EHRs all over the world.

“Amongst Type of Software, Standalone segment holds the major share.”

Based on the type of Software, the market is bifurcated into Standalone and Integrated. The Standalone segment dominated the market in 2020 owing to its easy-to-use tools and advanced features. Standalone software applications focus only on a specific register for instance cardiovascular, rare disease, diabetes, and cancer patient details. The Integrated segment is expected to show significant growth during the forecast period. The Integrated system is an accumulation of software at the national level which helps to track affected geographic locations and evaluate the clinical intervention.

“Amongst Database Type, Commercial segment holds the major share.”

Based on Database Type, the market is bifurcated into Commercial and Public. The Commercial segment dominated the market in 2020 due to its enhanced data security in comparison to the public data base. The Public segment is expected to grow at lucrative growth during the forecasted period owing to the rising number of research organizations.

“Amongst Functionality, Population Health Management segment holds the major share.”

Based on Functionality, the market is fragmented into Population Health Management, Health Information Exchange, Patient Care Management, Point-Of-Care, Medical Research & Clinical Studies, and Product Outcome Evaluation. The Population Health Management segment dominated the market in 2020 and is expected to grow at lucrative growth during the forecasted period owing to the rising demand for solutions supporting value-based care delivery.

“Amongst End-Use, Government & third parties segment holds the major share.”

Based on End-use, the market is fragmented into Government & third parties, Hospitals & medical practices, private payers, pharma & medical device companies, and research organization. The Government & third-party segment dominated the market in 2020 owing to the implementation of this software by the government in both developed and developing countries to decrease the chronic disease burden.

“Amongst Deployment Model, On-premise segment holds the major share.”

Based on Deployment Model, the market is bifurcated into On-premise and Web/Cloud-based. The On-premise segment dominated the market in 2020 owing to its easy retrieval, data security, and ease of access. Web/cloud-based solution is expected to exhibit lucrative growth during the forecast period owing to their advanced features such as real-time tracking and remote access to data.

“North America region signifies one of the largest markets and is expected to be the fastest-growing markets of Patient Registry Software market.”

For a better understanding of the market adoption of Patient Registry Software, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America is expected to dominate the Patient Registry Software market on account of the Increasing target population coupled with the rising prevalence of diseases and the need for population-based registries. Some of the major players operating in the market include IBM Corporation, IQVIA Holdings, OpenText Corporation, Optum, Premier, Inc., ArborMetrix, FIGmd, McKesson Corporation, Syneos Health, and Dacima Software. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry

Customization Options:

The Patient Registry Software market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

1.1.Market Definitions
1.2.Limitation
1.3.Stake Holders
1.4.Currency used in Report
2.1.Research Process of the Patient Registry Software Market
2.2.Research Methodology of the Patient Registry Software Market
2.3.Forecasting Method
2.4.Respondent Profile
2.5.Main Objective of the Patient Registry Software Market Study
3MARKET SYNOPSIS
4EXECUTIVE SUMMARY

 

5GLOBAL PATIENT REGISTRY SOFTWARE MARKET COVID-19 IMPACT
6GLOBAL PATIENT REGISTRY SOFTWARE MARKET REVENUE (USD BN), 2019-2027F
7.1.Disease Registry
 7.1.1.Cardiovascular
 7.1.2.Diabetes
 7.1.3.Cancer
 7.1.4.Rare disease
 7.1.5.Asthma
 7.1.6.Others
7.2.Health Service Registry
7.3.Product Registry
 7.3.1.Medical Device
 7.3.2.Drug
8.1.Standalone
8.2.Integrated
9.1.Commercial
9.2.Public
10.1.Population Health Management
10.2.Health Information Exchange
10.3.Patient Care Management
10.4.Point-Of-Care
10.5.Medical Research & Clinical Studies
10.6.Product Outcome Evaluation
11.1.Government & third party
11.2.Hospitals & medical practices
11.3.private payers
11.4.pharma & medical device companies
11.5.Research organization
12.1.On-premise
12.2.Web/Cloud-based
13.1.North America Patient Registry Software Market 
 13.1.1.United States
 13.1.2.Canada
 13.1.3.Rest of North America
13.2.Europe Patient Registry Software Market 
 13.2.1.Germany
 13.2.2.U.K.
 13.2.3.France
 13.2.4.Rest of Europe
13.3.Asia Pacific Patient Registry Software Market
 13.3.1.China
 13.3.2.Japan
 13.3.3.India
 13.3.4.Australia
 13.3.5.Rest of Asia Pacific
13.4.Rest of World Patient Registry Software Market 
14.1.Market Drivers
14.2.Market Challenges
14.3.Impact Analysis
15Patient Registry Software MARKET OPPORTUNITIES
16Patient Registry Software MARKET TRENDS
17LEGAL & REGULATORY FRAMEWORK
18.1.Demand Side Analysis
18.2.Supply Side Analysis
 18.2.1.Top Product Launches
 18.2.2.Top Business Partnerships
 18.2.3.Top Business Expansions, Investments and Divestitures
 18.2.4.Top Merger and Acquisitions

19 VALUE CHAIN ANALYSIS

20.1.Competitive Landscape
 20.1.1.Company Shares, By Revenue
21.1.IBM Corporation
21.2.IQVIA Holdings
21.3.OpenText Corporation
21.4.Optum
21.5.Premier, Inc. 
21.6.ArborMetrix 
21.7.FIGmd 
21.8.McKesson Corporation 
21.9.Syneos Health
21.10.Dacima Software
22DISCLAIMER

Research Methodology

Analyzing the historical market, estimation of the current market, and forecasting the future market of the Global Patient Registry Software market were the three major steps undertaken to create and analyze the adoption of Patient Registry Software for the different End-uses such as Government & third parties, Hospitals & medical practices, private payers, pharma & medical device companies, and research organization. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the Patient Registry Software sector. Post assumption and validation of market numbers through primary interviews, we employed a top-down approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

The detailed secondary study was conducted to obtain the historical market size of the Patient Registry Software through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the Patient Registry Software market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments for major regions. Major segments included in the report are Types of Registry, Type of Software, Database Type, Functionality, End-Use, Deployment Model, and Region/Country. Further country-level analyses were conducted to evaluate the overall adoption of Patient Registry Software in every region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of Patient Registry Software. Further, we conducted factor analysis using dependent and independent variables such as the rising adoption of EHR all over the world.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Patient Registry Software Market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value (USD) and the adoption rate of Patient Registry Software across the major markets domestically
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the Patient Registry Software market in terms of services offered. Also, the growth strategies adopted by these players to compete in the fast-growing market.

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the Patient Registry Software market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas Types of Registry, Type of Software, Database Type, Functionality, End-Use, Deployment Model, and Region/Country of the Patient Registry Software market.

Main Objective of the Patient Registry Software Market Study

The current & future market trends of Patient Registry Software were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of Patient Registry Software Market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments of the sector
  • Segments in the study include Types of Registry, Type of Software, Database Type, Functionality, End-Use, Deployment Model, and Region/Country
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors pertaining to the industry
  • Analyze the current and forecast market size of the Patient Registry Software category across the globe. Major regions analyzed in the report include North America (US, Canada, Rest of North America), Europe (Germany, UK, France, Rest of Europe), Asia-Pacific (China, India, Australia, Singapore, Rest of Asia-Pacific), & Rest of World
  • Company profiles of the Patient Registry Software market and the growth strategies adopted by the market players to sustain in the fast-growing market

Deep dive regional level analysis of the industry